Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) Tax Provisions: 2009-2025

Historic Tax Provisions for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $9.8 million.

  • BIO-TECHNE's Tax Provisions rose 49.23% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.4 million, marking a year-over-year increase of 20.83%. This contributed to the annual value of $76.2 million for FY2025, which is 31.99% up from last year.
  • BIO-TECHNE's Tax Provisions amounted to $9.8 million in Q3 2025, which was down 78.67% from $46.0 million recorded in Q2 2025.
  • Over the past 5 years, BIO-TECHNE's Tax Provisions peaked at $46.0 million during Q2 2025, and registered a low of -$1.6 million during Q3 2021.
  • For the 3-year period, BIO-TECHNE's Tax Provisions averaged around $17.9 million, with its median value being $10.0 million (2023).
  • In the last 5 years, BIO-TECHNE's Tax Provisions tumbled by 126.88% in 2021 and then surged by 18,075.00% in 2022.
  • Quarterly analysis of 5 years shows BIO-TECHNE's Tax Provisions stood at $14.1 million in 2021, then increased by 16.32% to $16.4 million in 2022, then plummeted by 63.94% to $5.9 million in 2023, then spiked by 34.85% to $8.0 million in 2024, then soared by 49.23% to $9.8 million in 2025.
  • Its Tax Provisions was $9.8 million in Q3 2025, compared to $46.0 million in Q2 2025 and $15.7 million in Q1 2025.